$0.32
0.00%
Nasdaq, Oct 06, 04:00 pm EDT.
ISIN
US0345691036
Symbol
ANEB

Anebulo Pharmaceuticals Inc Stock price

$0.32
-0.04 10.76% 1M
-0.33 50.91% 6M
-0.69 68.32% YTD
-1.99 86.15% 1Y
-2.64 89.19% 3Y
-6.24 95.12% 5Y
-6.68 95.43% 10Y
-6.68 95.43% 20Y
Nasdaq, Closing price Wed, Oct 07 2026
+0.00 0.00%
ISIN
US0345691036
Symbol
ANEB
Industry

Is Anebulo Pharmaceuticals Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.

Key metrics

Basic
Market capitalization
$13.1m
Enterprise Value
$4.0m
Net debt
positive
Cash
$9.0m
Shares outstanding
41.1m
Valuation
P/E
negative
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
negative | negative
P/B
1.6
Financial Health
Equity Ratio
96.0%
Return on Equity
-72.8%
ROCE
-114.8%
ROIC
-
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$1.0m | -
SBC as % of FCF
-
SBC Growth 1Y
-12.7%
Share Count Growth 1Y
0.2%
Shareholder Yield
-0.2%
Financials
Revenue | estimate
$0.0 | $0.0
EBITDA
-
EBIT
$-9.1m
Net Income
$-8.0m
Free Cash Flow | ex SBC
$-5.8m | $-6.9m
Growth
Revenue | estimate
- | -
EBITDA
-
EBIT
-13.8%
Net Income
-4.2%
Free Cash Flow
12.2%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow | ex SBC
- | -
More
EPS
$-0.2
FCF per Share
$-0.1
Short interest
2.1%
Employees
3
Rev per Employee
$0.0

Anebulo Pharmaceuticals Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Anebulo Pharmaceuticals Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Anebulo Pharmaceuticals Inc forecast:

Hold
50%
Sell
50%

Financial data from Anebulo Pharmaceuticals Inc

Dec '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.36 5.36
26% 26%
-
- Research and Development Expense 3.74 3.74
0% 0%
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -9.10 -9.10
14% 14%
-
Net Profit -7.98 -7.98
4% 4%
-

In millions USD.

Don't miss a Thing! We will send you all news about Anebulo Pharmaceuticals Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Anebulo Pharmaceuticals, Inc. engages in the provision of pharmaceutical services. The firm product candidate is ANEB-001, a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The company was founded by Lawyer Joseph F on April 23, 2020 and is headquartered in Lakeway, TX.

Head office United States
CEO Mr. Cunningham
Employees 3
Founded 2020
Website www.anebulo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today